Ophthotech reported $-49263000 in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Alimera Sciences ALIM:US $ -3.1M 2.86M
Applied Genetic Technologies AGTC:US $ -14.24M 4.87M
Insmed INSM:US $ -95144000 908K
Nektar Therapeutics NKTR:US $ -158.97M 68.7M
Novartis NOVN:VX SF 4129M 217M
Ophthotech OPHT:US $ -49.26M 14.73M
Sanofi SAN:FP € 2660M 305M